home / stock / mycof / mycof news


MYCOF News and Press, New Age Brands From 10/01/21

Stock Information

Company Name: New Age Brands
Stock Symbol: MYCOF
Market: OTC
Website: mydecine.com

Menu

MYCOF MYCOF Quote MYCOF Short MYCOF News MYCOF Articles MYCOF Message Board
Get MYCOF Alerts

News, Short Squeeze, Breakout and More Instantly...

MYCOF - Mydecine Completes Spin-Out of U.S. Cannabis Assets

DENVER, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA ) (“Mydecine” or the “Company”) , a biopharmaceutical company focused on the treatment of mental health and addiction, today announced...

MYCOF - Psychedelics Called the 'Next Frontier' for Investors, Also Offer Promising Treatments

NetworkNewsWire Editorial Coverage : The fact that psychedelics is a nascent industry doesn’t seem to be discouraging savvy investors exploring the opportunities. A recent Fortune article noted that “despite being an industry in its early stages, the potential for psychedeli...

MYCOF - Mydecine Innovations Group Receives Shareholder and Court Approval for Spin-Out of Cannabis Subsidiaries

Mydecine Innovations Group Inc. (NEO:MYCO) (OTC:MYCOF) (“ Mydecine ” or the “ Company ”) is pleased to announce the previously announced spin-out transaction, to be implemented through a statutory plan of arrangement (the “ Arrangement ...

MYCOF - Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data

DENVER, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) (“Mydecine” or the “Company”), a biopharmaceutical company focused on the treatment of mental health and addiction, today announced that it has filed i...

MYCOF - National Suicide Prevention Week Shines Light on Psychedelic Treatments

FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 9, 2021 – National Suicide Prevention Week is here and it’s not only an opportunity to talk about mental health, but to also look at potential treatments. Suicide re...

MYCOF - Mydecine Innovations Group Announces MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical Trial

Dr. Matthew Johnson will lead research to look at the science and efficacy of MYCO-001 for the treatment of smoking cessation and nicotine dependence DENVER, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group ™ (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a bioph...

MYCOF - Mydecine to Participate in Upcoming Conferences in September 2021

DENVER, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders and addiction...

MYCOF - Mydecine Innovations Group Announces Mailing of Management Information Circular and Provides Update on Spin-Out of U.S. Cannabis Assets

DENVER, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (“ Mydecine ” or the “ Company ”), is pleased to announce that it has filed and mailed its management information circular (the “ Information Circu...

MYCOF - The Daily Hit: August 18, 2021

It’s time for your Daily Hit of cannabis financial news for August 18, 2021. On The Site Eaze Private cannabis delivery company Eaze is buying multi-state retail operator Green Dragon and will provide service to cust...

MYCOF - Mydecine Innovations Group signs five-year Master Collaboration Research Agreement with Johns Hopkins University School of Medicine

DENVER, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) announces it has signed a five-year research agreement with Johns Hopkins University (JHU) School of Medicine, with research to be led by Professor of Psychiatry and Behavioral Sciences at Johns Ho...

Previous 10 Next 10